摘要
Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
| 貢獻的翻譯標題 | USE OF IL-20 ANTAGONISTS FOR TREATING LIVER DISEASES |
|---|---|
| 原文 | English |
| 專利號 | 9365652 |
| 出版狀態 | Published - 1800 |